Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience.
Francisco Emilio Vera-Badillo
No relevant relationships to disclose
Raya Leibowitz-Amit
No relevant relationships to disclose
Arnoud Templeton
Honoraria - Astellas Pharma
Jo-An Seah
No relevant relationships to disclose
Srikala S. Sridhar
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Ian Tannock
No relevant relationships to disclose
Anthony Michael Joshua
No relevant relationships to disclose